Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2001;104:1598-1603
doi: 10.1161/hc3901.096721
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mallat, Z.
Right arrow Articles by Tedgui, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mallat, Z.
Right arrow Articles by Tedgui, A.
Right arrowPubmed/NCBI databases
*OMIM
*Substance via MeSH
Medline Plus Health Information
*Stroke
Related Collections
Right arrow Pathophysiology
Right arrow Growth factors/cytokines
Right arrow Carotid Stenosis

(Circulation. 2001;104:1598.)
© 2001 American Heart Association, Inc.


Clinical Investigation and Reports

Expression of Interleukin-18 in Human Atherosclerotic Plaques and Relation to Plaque Instability

Ziad Mallat, MD, PhD; Anne Corbaz, BSc; Alexandra Scoazec, BSc; Sandrine Besnard, PhD; Guy Lesèche, MD; Yolande Chvatchko, PhD; Alain Tedgui, PhD

From the Institut National de la Santé et de la Recherche Médicale, INSERM U541, Institut Fédératif de Recherche Circulation Paris VII, Hôpital Lariboisière, Paris (Z.M., A.S., S.B., G.L., A.T.), and Service de chirurgie Thoracique et Vasculaire, Hôpital Beaujon, Clichy (G.L.), France; and Serono Pharmaceutical Research Institute, Ares-Serono International SA (A.C., Y.C.), Geneva, Switzerland.

Correspondence to Ziad Mallat, MD, PhD, INSERM U541, Hôpital Lariboisière, 41 Blvd de la chapelle, 75010 Paris, France. E-mail ziad.mallat{at}inserm.lrb.ap-hop-paris.fr

Background— Interleukin (IL)-18 is a potent proinflammatory cytokine with potential atherogenic properties. Its expression and role in atherosclerosis, however, are unknown.

Methods and Results— In the present study, we examined stable and unstable human carotid atherosclerotic plaques retrieved by endarterectomy for the presence of IL-18 using reverse transcription-polymerase chain reaction (PCR), Western blot, and immunohistochemical techniques. IL-18 was highly expressed in the atherosclerotic plaques compared with control normal arteries and was localized mainly in plaque macrophages. IL-18 receptor was also upregulated in plaque macrophages and endothelial cells, suggesting potential biological effects. To examine the role of IL-18 in atherosclerosis, we determined the relation between IL-18 mRNA expression and signs of plaque instability using real-time quantitative PCR. Interestingly, significantly higher levels of IL-18 mRNA were found in symptomatic (unstable) plaques than asymptomatic (stable) plaques (P<0.01).

Conclusions— These results suggest, for the first time, a major role for IL-18 in atherosclerotic plaque destabilization leading to acute ischemic syndromes.


Key Words: atherosclerosis • interleukin • stroke




This article has been cited by other articles:


Home page
CirculationHome page
N. Yajima, M. Takahashi, H. Morimoto, Y. Shiba, Y. Takahashi, J. Masumoto, H. Ise, J. Sagara, J. Nakayama, S. Taniguchi, et al.
Critical Role of Bone Marrow Apoptosis-Associated Speck-Like Protein, an Inflammasome Adaptor Molecule, in Neointimal Formation After Vascular Injury in Mice
Circulation, June 17, 2008; 117(24): 3079 - 3087.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J.-S. Silvestre, Z. Mallat, A. Tedgui, and B. I. Levy
Post-ischaemic neovascularization and inflammation
Cardiovasc Res, May 1, 2008; 78(2): 242 - 249.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. S. Wang, W. Shi, X. Wang, L. Velky, S. Greenlee, M. T. Wang, T. A. Drake, and A. J. Lusis
Mapping, Genetic Isolation, and Characterization of Genetic Loci That Determine Resistance to Atherosclerosis in C3H Mice
Arterioscler. Thromb. Vasc. Biol., December 1, 2007; 27(12): 2671 - 2676.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. R. Thompson, D. Novick, C. J. Stock, J. Sanders, D. Brull, J. Cooper, P. Woo, G. Miller, M. Rubinstein, and S. E. Humphries
Free Interleukin (IL)-18 Levels, and the Impact of IL18 and IL18BP Genetic Variation, in CHD Patients and Healthy Men
Arterioscler. Thromb. Vasc. Biol., December 1, 2007; 27(12): 2743 - 2749.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
S. R. Thompson, P. A. McCaskie, J. P. Beilby, J. Hung, M. Jennens, C. Chapman, P. Thompson, and S. E. Humphries
IL18 Haplotypes Are Associated with Serum IL-18 Concentrations in a Population-Based Study and a Cohort of Individuals with Premature Coronary Heart Disease
Clin. Chem., December 1, 2007; 53(12): 2078 - 2085.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
V. L. King, L. A. Cassis, and A. Daugherty
Interleukin-4 Does Not Influence Development of Hypercholesterolemia or Angiotensin II-Induced Atherosclerotic Lesions in Mice
Am. J. Pathol., December 1, 2007; 171(6): 2040 - 2047.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
J. Evans, M. Collins, C. Jennings, L. van der Merwe, I. Soderstrom, T. Olsson, N. S Levitt, E. V Lambert, and J. H Goedecke
The association of interleukin-18 genotype and serum levels with metabolic risk factors for cardiovascular disease
Eur. J. Endocrinol., November 1, 2007; 157(5): 633 - 640.
[Abstract] [Full Text] [PDF]


Home page
Vasc MedHome page
H.R.S. Girn, N.M. Orsi, and S. Homer-Vanniasinkam
An overview of cytokine interactions in atherosclerosis and implications for peripheral arterial disease
Vascular Medicine, November 1, 2007; 12(4): 299 - 309.
[Abstract] [PDF]


Home page
JNMHome page
L. G. Spagnoli, E. Bonanno, G. Sangiorgi, and A. Mauriello
Role of Inflammation in Atherosclerosis
J. Nucl. Med., November 1, 2007; 48(11): 1800 - 1815.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
J. M Bruun, B. Stallknecht, J. W Helge, and B. Richelsen
Interleukin-18 in plasma and adipose tissue: effects of obesity, insulin resistance, and weight loss
Eur. J. Endocrinol., October 1, 2007; 157(4): 465 - 471.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Zirlik, S. M. Abdullah, N. Gerdes, L. MacFarlane, U. Schonbeck, A. Khera, D. K. McGuire, G. L. Vega, S. Grundy, P. Libby, et al.
Interleukin-18, the Metabolic Syndrome, and Subclinical Atherosclerosis: Results From the Dallas Heart Study
Arterioscler. Thromb. Vasc. Biol., September 1, 2007; 27(9): 2043 - 2049.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
C Hamid, K Norgate, D P D'Cruz, M A Khamashta, M Arno, J D Pearson, G Frampton, and J J Murphy
Anti-{beta}2GPI-antibody-induced endothelial cell gene expression profiling reveals induction of novel pro-inflammatory genes potentially involved in primary antiphospholipid syndrome
Ann Rheum Dis, August 1, 2007; 66(8): 1000 - 1007.
[Abstract] [Full Text] [PDF]


Home page
J. Dent. Res.Home page
A. Orozco, E. Gemmell, M. Bickel, and G.J. Seymour
Interleukin 18 and Periodontal Disease
J. Dent. Res., July 1, 2007; 86(7): 586 - 593.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
N. P. Kadoglou, D. Perrea, F. Iliadis, N. Angelopoulou, C. Liapis, and M. Alevizos
Exercise Reduces Resistin and Inflammatory Cytokines in Patients With Type 2 Diabetes
Diabetes Care, March 1, 2007; 30(3): 719 - 721.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
W. Koenig and N. Khuseyinova
Biomarkers of Atherosclerotic Plaque Instability and Rupture
Arterioscler. Thromb. Vasc. Biol., January 1, 2007; 27(1): 15 - 26.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
W. Koenig, N. Khuseyinova, J. Baumert, B. Thorand, H. Loewel, L. Chambless, C. Meisinger, A. Schneider, S. Martin, H. Kolb, et al.
Increased Concentrations of C-Reactive Protein and IL-6 but not IL-18 Are Independently Associated With Incident Coronary Events in Middle-Aged Men and Women: Results From the MONICA/KORA Augsburg Case-Cohort Study, 1984-2002
Arterioscler. Thromb. Vasc. Biol., December 1, 2006; 26(12): 2745 - 2751.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. Maffia, G. Grassia, P. Di Meglio, R. Carnuccio, L. Berrino, P. Garside, A. Ianaro, and A. Ialenti
Neutralization of Interleukin-18 Inhibits Neointimal Formation in a Rat Model of Vascular Injury
Circulation, August 1, 2006; 114(5): 430 - 437.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. Blankenberg, T. Godefroy, O. Poirier, H. J. Rupprecht, S. Barbaux, C. Bickel, V. Nicaud, R. Schnabel, F. Kee, C. Morrison, et al.
Haplotypes of the Caspase-1 Gene, Plasma Caspase-1 Levels, and Cardiovascular Risk
Circ. Res., July 7, 2006; 99(1): 102 - 108.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
R. Krogh-Madsen, P. Plomgaard, K. Moller, B. Mittendorfer, and B. K. Pedersen
Influence of TNF-{alpha} and IL-6 infusions on insulin sensitivity and expression of IL-18 in humans
Am J Physiol Endocrinol Metab, July 1, 2006; 291(1): E108 - E114.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
G. Stoll and M. Bendszus
Inflammation and Atherosclerosis: Novel Insights Into Plaque Formation and Destabilization
Stroke, July 1, 2006; 37(7): 1923 - 1932.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
L. B. Goldstein, R. Adams, M. J. Alberts, L. J. Appel, L. M. Brass, C. D. Bushnell, A. Culebras, T. J. DeGraba, P. B. Gorelick, J. R. Guyton, et al.
Primary Prevention of Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline.
Circulation, June 20, 2006; 113(24): e873 - e923.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Chandrasekar, S. Mummidi, L. Mahimainathan, D. N. Patel, S. R. Bailey, S. Z. Imam, W. C. Greene, and A. J. Valente
Interleukin-18-induced Human Coronary Artery Smooth Muscle Cell Migration Is Dependent on NF-{kappa}B- and AP-1-mediated Matrix Metalloproteinase-9 Expression and Is Inhibited by Atorvastatin
J. Biol. Chem., June 2, 2006; 281(22): 15099 - 15109.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
L. B. Goldstein, R. Adams, M. J. Alberts, L. J. Appel, L. M. Brass, C. D. Bushnell, A. Culebras, T. J. DeGraba, P. B. Gorelick, J. R. Guyton, et al.
Primary Prevention of Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline.
Stroke, June 1, 2006; 37(6): 1583 - 1633.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
A. Tedgui and Z. Mallat
Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways
Physiol Rev, April 1, 2006; 86(2): 515 - 581.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. Slevin, A. B. Elasbali, M. Miguel Turu, J. Krupinski, L. Badimon, and J. Gaffney
Identification of Differential Protein Expression Associated with Development of Unstable Human Carotid Plaques
Am. J. Pathol., March 1, 2006; 168(3): 1004 - 1021.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. J. Armstrong, D. A. Morrow, and M. S. Sabatine
Inflammatory Biomarkers in Acute Coronary Syndromes: Part I: Introduction and Cytokines
Circulation, February 14, 2006; 113(6): e72 - e75.
[Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
S G Baidya and Q-T Zeng
Helper T cells and atherosclerosis: the cytokine web
Postgrad. Med. J., December 1, 2005; 81(962): 746 - 752.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
Z. Mallat, Ph. G. Steg, J. Benessiano, M.-L. Tanguy, K. A. Fox, J.-P. Collet, O. H. Dabbous, P. Henry, K. F. Carruthers, A. Dauphin, et al.
Circulating Secretory Phospholipase A2 Activity Predicts Recurrent Events in Patients With Severe Acute Coronary Syndromes
J. Am. Coll. Cardiol., October 4, 2005; 46(7): 1249 - 1257.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
B. Thorand, H. Kolb, J. Baumert, W. Koenig, L. Chambless, C. Meisinger, T. Illig, S. Martin, and C. Herder
Elevated Levels of Interleukin-18 Predict the Development of Type 2 Diabetes: Results From the MONICA/KORA Augsburg Study, 1984-2002
Diabetes, October 1, 2005; 54(10): 2932 - 2938.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. L. Anderson and J. F. Carlquist
Cytokines, Interleukin-18, and the Genetic Determinants of Vascular Inflammation
Circulation, August 2, 2005; 112(5): 620 - 623.
[Full Text] [PDF]


Home page
CirculationHome page
L. Tiret, T. Godefroy, E. Lubos, V. Nicaud, D.-A. Tregouet, S. Barbaux, R. Schnabel, C. Bickel, C. Espinola-Klein, O. Poirier, et al.
Genetic Analysis of the Interleukin-18 System Highlights the Role of the Interleukin-18 Gene in Cardiovascular Disease
Circulation, August 2, 2005; 112(5): 643 - 650.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Chandrasekar, S. Mummidi, A. J. Valente, D. N. Patel, S. R. Bailey, G. L. Freeman, M. Hatano, T. Tokuhisa, and L. E. Jensen
The Pro-atherogenic Cytokine Interleukin-18 Induces CXCL16 Expression in Rat Aortic Smooth Muscle Cells via MyD88, Interleukin-1 Receptor-associated Kinase, Tumor Necrosis Factor Receptor-associated Factor 6, c-Src, Phosphatidylinositol 3-Kinase, Akt, c-Jun N-terminal Kinase, and Activator Protein-1 Signaling
J. Biol. Chem., July 15, 2005; 280(28): 26263 - 26277.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
H. Yamagami, K. Kitagawa, T. Hoshi, S. Furukado, H. Hougaku, Y. Nagai, and M. Hori
Associations of Serum IL-18 Levels With Carotid Intima-Media Thickness
Arterioscler. Thromb. Vasc. Biol., July 1, 2005; 25(7): 1458 - 1462.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
T. Skurk, H. Kolb, S. Muller-Scholze, K. Rohrig, H. Hauner, and C. Herder
The proatherogenic cytokine interleukin-18 is secreted by human adipocytes
Eur. J. Endocrinol., June 1, 2005; 152(6): 863 - 868.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
E. W. Raines and N. Ferri
Thematic Review Series: The Immune System and Atherogenesis. Cytokines affecting endothelial and smooth muscle cells in vascular disease
J. Lipid Res., June 1, 2005; 46(6): 1081 - 1092.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. Hung, B. M. McQuillan, C. M. L. Chapman, P. L. Thompson, and J. P. Beilby
Elevated Interleukin-18 Levels Are Associated With the Metabolic Syndrome Independent of Obesity and Insulin Resistance
Arterioscler. Thromb. Vasc. Biol., June 1, 2005; 25(6): 1268 - 1273.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. Sahar, R. S. Dwarakanath, M. A. Reddy, L. Lanting, I. Todorov, and R. Natarajan
Angiotensin II Enhances Interleukin-18 Mediated Inflammatory Gene Expression in Vascular Smooth Muscle Cells: A Novel Cross-Talk in the Pathogenesis of Atherosclerosis
Circ. Res., May 27, 2005; 96(10): 1064 - 1071.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. Tenger, A. Sundborger, J. Jawien, and X. Zhou
IL-18 Accelerates Atherosclerosis Accompanied by Elevation of IFN-{gamma} and CXCL16 Expression Independently of T Cells
Arterioscler. Thromb. Vasc. Biol., April 1, 2005; 25(4): 791 - 796.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
L. M. Biasucci
CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: Clinical Use of Inflammatory Markers in Patients With Cardiovascular Diseases: A Background Paper
Circulation, December 21, 2004; 110(25): e560 - e567.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R. de Nooijer, J.H. von der Thusen, C.J.N. Verkleij, J. Kuiper, J.W. Jukema, E.E. van der Wall, Th.J.C. van Berkel, and E.A.L. Biessen
Overexpression of IL-18 Decreases Intimal Collagen Content and Promotes a Vulnerable Plaque Phenotype in Apolipoprotein-E-Deficient Mice
Arterioscler. Thromb. Vasc. Biol., December 1, 2004; 24(12): 2313 - 2319.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
C.-K. Chiang, S.-P. Hsu, M.-F. Pai, Y.-S. Peng, T.-I Ho, S.-H. Liu, K.-Y. Hung, and T.-J. Tsai
Interleukin-18 is a strong predictor of hospitalization in haemodialysis patients
Nephrol. Dial. Transplant., November 1, 2004; 19(11): 2810 - 2815.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. Tedgui and Z. Mallat
Hypertension: A Novel Regulator of Adaptive Immunity in Atherosclerosis?
Hypertension, September 1, 2004; 44(3): 257 - 258.
[Full Text] [PDF]


Home page
J. Immunol.Home page
M. G. Netea, B. J. Kullberg, L. E. H. Jacobs, T. J. G. Verver-Jansen, J. van der Ven-Jongekrijg, J. M. D. Galama, A. F. H. Stalenhoef, C. A. Dinarello, and J. W. M. Van der Meer
Chlamydia pneumoniae Stimulates IFN-{gamma} Synthesis through MyD88-Dependent, TLR2- and TLR4-Independent Induction of IL-18 Release
J. Immunol., July 15, 2004; 173(2): 1477 - 1482.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. F. Escobar-Morreale, J. I. Botella-Carretero, G. Villuendas, J. Sancho, and J. L. San Millan
Serum Interleukin-18 Concentrations Are Increased in the Polycystic Ovary Syndrome: Relationship to Insulin Resistance and to Obesity
J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 806 - 811.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
S. Clement, S. S. Braithwaite, M. F. Magee, A. Ahmann, E. P. Smith, R. G. Schafer, and I. B. Hirsch
Management of Diabetes and Hyperglycemia in Hospitals
Diabetes Care, February 1, 2004; 27(2): 553 - 591.
[Full Text] [PDF]


Home page
Diabetes CareHome page
K. Esposito, R. Marfella, and D. Giugliano
Plasma Interleukin-18 Concentrations Are Elevated in Type 2 Diabetes
Diabetes Care, January 1, 2004; 27(1): 272 - 272.
[Full Text] [PDF]


Home page
J. Immunol.Home page
R. Gutzmer, K. Langer, S. Mommert, M. Wittmann, A. Kapp, and T. Werfel
Human Dendritic Cells Express the IL-18R and Are Chemoattracted to IL-18
J. Immunol., December 15, 2003; 171(12): 6363 - 6371.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
K. Esposito, F. Nappo, F. Giugliano, C. Di Palo, M. Ciotola, M. Barbieri, G. Paolisso, and D. Giugliano
Meal modulation of circulating interleukin 18 and adiponectin concentrations in healthy subjects and in patients with type 2 diabetes mellitus
Am. J. Clinical Nutrition, December 1, 2003; 78(6): 1135 - 1140.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Blankenberg, G. Luc, P. Ducimetiere, D. Arveiler, J. Ferrieres, P. Amouyel, A. Evans, F. Cambien, L. Tiret, and on behalf of the PRIME Study Group
Interleukin-18 and the Risk of Coronary Heart Disease in European Men: The Prospective Epidemiological Study of Myocardial Infarction (PRIME)
Circulation, November 18, 2003; 108(20): 2453 - 2459.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. E. Szmitko, C.-H. Wang, R. D. Weisel, J. R. de Almeida, T. J. Anderson, and S. Verma
New Markers of Inflammation and Endothelial Cell Activation: Part I
Circulation, October 21, 2003; 108(16): 1917 - 1923.
[Full Text] [PDF]


Home page
Diabetes CareHome page
Y. Aso, K.-i. Okumura, K. Takebayashi, S. Wakabayashi, and T. Inukai
Relationships of Plasma Interleukin-18 Concentrations to Hyperhomocysteinemia and Carotid Intimal-Media Wall Thickness in Patients With Type 2 Diabetes
Diabetes Care, September 1, 2003; 26(9): 2622 - 2627.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. Elhage, J. Jawien, M. Rudling, H.-G. Ljunggren, K. Takeda, S. Akira, F. Bayard, and G. K Hansson
Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice
Cardiovasc Res, July 1, 2003; 59(1): 234 - 240.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
J. H. Von der Thusen, J. Kuiper, T. J. C. Van Berkel, and E. A. L. Biessen
Interleukins in Atherosclerosis: Molecular Pathways and Therapeutic Potential
Pharmacol. Rev., March 1, 2003; 55(1): 133 - 166.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
Z Mallat, P Henry, R Fressonnet, S Alouani, A Scoazec, P Beaufils, Y Chvatchko, and A Tedgui
Increased plasma concentrations of interleukin-18 in acute coronary syndromes
Heart, December 1, 2002; 88(5): 467 - 469.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
C. Lubeseder-Martellato, E. Guenzi, A. Jorg, K. Topolt, E. Naschberger, E. Kremmer, C. Zietz, E. Tschachler, P. Hutzler, M. Schwemmle, et al.
Guanylate-Binding Protein-1 Expression Is Selectively Induced by Inflammatory Cytokines and Is an Activation Marker of Endothelial Cells during Inflammatory Diseases
Am. J. Pathol., November 1, 2002; 161(5): 1749 - 1759.